基于前列腺周围脂肪组织18F-PSMA-1007 PET/CT的动态在线列线图预测前列腺癌短期预后:一项多中心研究
该多中心回顾性研究纳入268例术前行18F-PSMA-1007 PET/CT的前列腺癌患者,从PET和CT提取前列腺周围脂肪组织影像组学特征构建Rad-score,并结合临床变量建立列线图预测术后持续PSA定义的短期预后。影像组学-临床联合模型在训练、内部验证和外部验证队列的AUC分别为0.85、0.77和0.84,校准曲线良好,决策曲线显示临床效用更佳。
要点
- 基于前列腺周围脂肪组织18F-PSMA-1007 PET/CT的影像组学-临床联合列线图可用于术前个体化预测前列腺癌短期预后。
- 联合模型在训练、内部验证和外部验证队列的AUC分别为0.85、0.77和0.84。
- Rad-score由25个最优影像组学特征构成,在各队列中对持续PSA分类均显示良好区分度(均P<0.05)。
核心结论
- 影像组学-临床联合列线图可作为术前个体化预测前列腺癌患者短期预后的新工具。
研究设计与样本
- 多中心回顾性研究,纳入268例术前行18F-PSMA-1007 PET/CT的前列腺癌患者,分为训练队列156例、内部验证队列65例和外部验证队列47例;提取PET和CT的影像组学特征,以术后持续PSA定义短期预后。
诊断标准与关键数值
- Rad-score由经最大相关最小冗余和最小绝对收缩与选择算子筛选出的25个最优影像组学特征经逻辑回归构建,在各队列中对持续PSA分类均P<0.05;影像组学-临床联合模型在训练队列AUC为0.85(95%CI:0.78-0.91),内部验证队列AUC为0.77(95%CI:0.62-0.91),外部验证队列AUC为0.84(95%CI:0.70-0.93)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Rising prostate-specific antigen (PSA) levels following radical prostatectomy are indicative of a poor prognosis, which may associate with periprostatic adipose tissue (PPAT). Accordingly, we aimed to construct a dynamic online nomogram to predict tumor short-term prognosis based on 18F-PSMA-1007 PET/CT of PPAT.
METHODS: Data from 268 prostate cancer (PCa) patients who underwent 18F-PSMA-1007 PET/CT before prostatectomy were analyzed retrospectively for model construction and validation (training cohort: n = 156; internal validation cohort: n = 65; external validation cohort: n = 47). Radiomics features (RFs) from PET and CT were extracted. Then, the Rad-score was constructed using logistic regression analysis based on the 25 optimal RFs selected through maximal relevance and minimal redundancy, as well as the least absolute shrinkage and selection operator. A nomogram was constructed to predict short-term prognosis which determined by persistent PSA.
RESULTS: The Rad-score consisting of 25 RFs showed good discrimination for classifying persistent PSA in all cohorts (all P < 0.05). Based on the logistic analysis, the radiomics-clinical combined model, which contained the optimal RFs and the predictive clinical variables, demonstrated optimal performance at an AUC of 0.85 (95% CI: 0.78-0.91), 0.77 (95% CI: 0.62-0.91) and 0.84 (95% CI: 0.70-0.93) in the training, internal validation and external validation cohorts. In all cohorts, the calibration curve was well-calibrated. Analysis of decision curves revealed greater clinical utility for the radiomics-clinical combined nomogram.
CONCLUSION: The radiomics-clinical combined nomogram serves as a novel tool for preoperative individualized prediction of short-term prognosis among PCa patients.
引用
- Bian S, Hong W, Su X, et al. A dynamic online nomogram predicting prostate cancer short-term prognosis based on 18F-PSMA-1007 PET/CT of periprostatic adipose tissue: a multicenter study. Abdom Radiol (NY). 2024. PMID: 38890216. doi:10.1007/s00261-024-04421-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。